Li, Qiuhong

USPTO Trademark & Patent Filings

Trademark applications and grants for Li, Qiuhong. Li, Qiuhong has 3 trademark applications. The latest application filed is for "LORMBWEP"

Company Profile

Li, QiuHong
qiuhong li
Li; Qiuhong - Gainesville FL
Li; Qiuhong - Gainsville PA
Li; Qiuhong - Beijing CN

Entity Type	INDIVIDUAL
Address	No.16,Group 1,Guanyuantou Village Yishi Town,Linyi County Yuncheng, Shanxi CHINA 044100

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks Patents

Patent Applications

Patent Application	Date
ORAL DELIVERY OF ANGIOTENSIN CONVERTING ENZYME 2 (ACE2) OR ANGIOTENSIN-(1-7)-BIOENCAPSULATED IN PLANT CELLS ATTENUATES PULMONARY HYPERTENSION, CARDIAC DYSFUNCTION AND DEVELOPMENT OF AUTOIMMUNE AND EXPERIMENTALLY INDUCED OCULAR DISORDERS 20220233659 - 17/591151 Daniell; Henry ; et al.	2022-07-28
DELIVERY OF CARD PROTEIN AS THERAPY FOR OCCULAR INFLAMMATION 20210371481 - 17/204627 Ildefonso; Cristhian J. ; et al.	2021-12-02
DELIVERY OF NRF2 AS THERAPY FOR PROTECTION AGAINST REACTIVE OXYGEN SPECIES 20210300978 - 17/342120 Ildefonso; Cristhian J. ; et al.	2021-09-30
ORAL DELIVERY OF ANGIOTENSIN CONVERTING ENZYME 2 (ACE2) OR ANGIOTENSIN-(1-7)-BIOENCAPSULATED IN PLANT CELLS ATTENUATES PULMONARY HYPERTENSION, CARDIAC DYSFUNCTION AND DEVELOPMENT OF AUTOIMMUNE AND EXPERIMENTALLY INDUCED OCULAR DISORDERS 20210145943 - 17/001667 Daniell; Henry ; et al.	2021-05-20
ORAL DELIVERY OF ANGIOTENSIN CONVERTING ENZYME 2 (ACE2) OR ANGIOTENSIN-(1-7)-BIOENCAPSULATED IN PLANT CELLS ATTENUATES PULMONARY 20190358304 - 16/425243 Daniell; Henry ; et al.	2019-11-28
Genetically modified probiotics for oral delivery of renin-angiotensin related therapeutic proteins and peptides 11,377,479 - 16/333,044 Li , et al. July 5, 2	2022-07-05
Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7)-bioencapsulated in plant cells attenuates pulmonary hypertension, cardiac dysfunction and development of autoimmune and experimentally induced ocular disorders 11,241,487 - 17/001,667 Daniell , et al. February 8, 2	2022-02-08
Multilayer-structure absorbent core for nursing pad, and method for preparing absorbent core 11,179,281 - 14/277,947 Li November 23, 2	2021-11-23
Delivery of Nrf2 as therapy for protection against reactive oxygen species 11,053,291 - 15/120,318 Ildefonso , et al. July 6, 2	2021-07-06
Delivery of card protein as therapy for occular inflammation 10,981,961 - 14/775,289 Ildefonso , et al. April 20, 2	2021-04-20

Patent Grants & Applications

Trademark Applications

Mark Image Registration \| Serial	Trademark Application Date
"LORMBWEP" 97465799	LORMBWEP 2022-06-19
"INSPIRATION INDUSTRY" 5892376 88006996	INSPIRATION INDUSTRY 2018-06-20
"VIPO" 87545670	VIPO 2017-07-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.